Search research articles
Contact Us
Filters
Showing results (31-40 of 61) with videos related to
Page
of 7
Sort By:
Clinical Genitourinary Cancer
|
January 20, 2024
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Amanda Nizam, Ryan K Rader, Alice Tzeng, et al.
American Journal of Hematology
|
October 15, 2013
Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia
Moshe C Ornstein, Sudipto Mukherjee, Sanjay Mohan, et al.
Targeted Oncology
|
July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone
Iris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Patient Preference and Adherence
|
August 20, 2024
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
Moshe C Ornstein, Lisa C Rosenblatt, Xin Yin, et al.
Urology
|
May 29, 2025
Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition: Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)
Jason M Scovell, Brian I Rini, Venkatesh Krishnamurthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Moshe C Ornstein, Laura S Wood, Paul Elson, et al.
Clinical Genitourinary Cancer
|
September 16, 2018
Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery
Nima Almassi, Tianming Gao, Byron Lee, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
Haris Zahoor, Pedro C Barata, Xuefei Jia, et al.
Leukemia & Lymphoma
|
January 8, 2015
Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy
Moshe C Ornstein, Sudipto Mukherjee, Michael Keng, et al.
Clinical Genitourinary Cancer
|
March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
Moshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 61) with videos related to
Sort By:
Page
of 7
Clinical Genitourinary Cancer
|
January 20, 2024
Safety and Efficacy Outcomes in Immune Checkpoint Inhibitor-Treated Patients With Metastatic Urothelial Carcinoma Requiring Treatment Interruption or Discontinuation Due to Immune-Related Adverse Events
Amanda Nizam, Ryan K Rader, Alice Tzeng, et al.
American Journal of Hematology
|
October 15, 2013
Predictive factors for latency period and a prognostic model for survival in patients with therapy-related acute myeloid leukemia
Moshe C Ornstein, Sudipto Mukherjee, Sanjay Mohan, et al.
Targeted Oncology
|
July 15, 2020
Identifying Prostate Surface Antigen Patterns of Change in Patients with Metastatic Hormone Sensitive Prostate Cancer Treated with Abiraterone and Prednisone
Iris Y Sheng, Jaleh Fallah, Ruby Gupta, et al.
Patient Preference and Adherence
|
August 20, 2024
Treatment Preferences Among Patients with Renal Cell Carcinoma: Results from a Discrete Choice Experiment
Moshe C Ornstein, Lisa C Rosenblatt, Xin Yin, et al.
Urology
|
May 29, 2025
Safety of Partial and Radical Nephrectomy for Complex Locally Advanced Renal Cell Carcinoma After Neo-Adjuvant Immune Checkpoint Inhibition: Analysis From a Phase 1b Trial (Durvalumab +/- Tremelimumab)
Jason M Scovell, Brian I Rini, Venkatesh Krishnamurthi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 24, 2017
A Phase II Study of Intermittent Sunitinib in Previously Untreated Patients With Metastatic Renal Cell Carcinoma
Moshe C Ornstein, Laura S Wood, Paul Elson, et al.
Clinical Genitourinary Cancer
|
September 16, 2018
Impact of Neoadjuvant Chemotherapy on Pathologic Response in Patients With Upper Tract Urothelial Carcinoma Undergoing Extirpative Surgery
Nima Almassi, Tianming Gao, Byron Lee, et al.
Journal for Immunotherapy of Cancer
|
October 19, 2018
Patterns, predictors and subsequent outcomes of disease progression in metastatic renal cell carcinoma patients treated with nivolumab
Haris Zahoor, Pedro C Barata, Xuefei Jia, et al.
Leukemia & Lymphoma
|
January 8, 2015
Impact of vancomycin-resistant enterococcal bacteremia on outcome during acute myeloid leukemia induction therapy
Moshe C Ornstein, Sudipto Mukherjee, Michael Keng, et al.
Clinical Genitourinary Cancer
|
March 3, 2019
Myalgia and Arthralgia Immune-related Adverse Events (irAEs) in Patients With Genitourinary Malignancies Treated With Immune Checkpoint Inhibitors
Moshe C Ornstein, Cassandra Calabrese, Laura S Wood, et al.
Page
of 7